Methanex Reports $89 Million Loss in Q4 2025
Methanex Corp's stock fell sharply by 13.15% as it hit a 5-day low following the announcement of a significant quarterly loss.
The company reported a loss of $89 million in Q4 2025, translating to a loss of $1.15 per share, which is a significant decline from a profit of $45 million in the same quarter last year. Additionally, revenues increased by approximately 2% year-over-year to $968.8 million but fell short of the Zacks Consensus Estimate of $994.4 million, indicating weakened market demand and intensified competition. The disappointing earnings report has raised concerns about the company's profitability and future outlook, leading to a sharp decline in stock price.
This financial performance highlights the challenges Methanex faces in a competitive market, and the stock's decline may reflect investor concerns about its ability to navigate these pressures effectively.
Trade with 70% Backtested Accuracy
Analyst Views on MEOH
About MEOH
About the author

- Share Sale Details: OCI N.V.'s wholly owned subsidiary, OCI Chemicals B.V., sold 3,331,346 common shares of Methanex Corp. on March 13 through a block trade, representing approximately 4.3% of the company's outstanding shares, generating net proceeds of about $172.6 million, showcasing OCI's agility in capital management.
- Ownership Change: Prior to the sale, OCI held 9,944,308 shares of Methanex, about 12.9%, and after the transaction, OCI now controls 6,612,962 shares, or about 8.6%, indicating that OCI maintains a significant stake in Methanex, which may continue to influence strategic decisions.
- Market Reaction: OCI's closing price on the Amsterdam Stock Exchange was €3.7500, up 0.81% from the previous trading day, reflecting a positive market response to the share transaction, potentially boosting investor confidence in OCI's future prospects.
- Financial Impact: This transaction not only provides OCI with substantial cash flow but may also be used for further investments or debt repayment, thereby optimizing its capital structure and enhancing the company's financial flexibility and market competitiveness.
- Share Sale Overview: OCI Chemicals B.V. sold 3,331,346 common shares of Methanex (MEOH), representing about 4.3% of the outstanding shares, at a price of $51.80 per share, resulting in net proceeds of approximately $172.6 million after fees.
- Change in Ownership: Following this transaction, OCI now owns or controls 6,612,962 shares of Methanex, which is about 8.6% of the total outstanding shares, indicating a decrease in its stake that may impact its influence in corporate decisions.
- Transaction Timing: The sale was executed as a block trade on March 13, 2026, reflecting OCI's strategic timing in the market to optimize its investment portfolio.
- Market Reaction Potential: While this sale may not have an immediate impact on Methanex's stock price, OCI's divestment could raise market scrutiny on Methanex's future performance, especially given its Q4 2025 earnings report missed expectations.

Stock Sale Announcement: OCI Chemicals B.V. plans to sell 3.33 million shares of its common stock on March 13.
Market Value: The total market value of the shares being sold is approximately $196.02 million.
- Stock Price Surge: Dow Inc. shares rallied 9.3% to close at $37.58, driven by notable trading volume that indicates strong market interest, reflecting the company's competitive advantage amid global supply chain disruptions.
- Analyst Upgrade: Citigroup upgraded Dow's rating from 'Neutral' to 'Buy' and raised the price target to $40, which may further boost investor confidence and support the stock's upward momentum.
- Disappointing Earnings Outlook: Dow is expected to report a quarterly loss of $0.34 per share, representing a staggering year-over-year decline of 1800%, while revenues are projected at $9.46 billion, down 9.3% from the previous year, highlighting the challenges the company faces.
- Earnings Estimate Revision: The consensus EPS estimate for Dow has been revised 2.5% lower over the last 30 days, and such negative trends typically do not correlate with stock price appreciation, prompting investors to monitor whether the recent price jump can sustain itself.
- Share Acquisition: Orion Resource Partners acquired an additional 77,291 shares of Methanex in Q4 2026, with an estimated transaction value of $2.88 million, reflecting confidence in Methanex's future growth prospects.
- Increased Asset Allocation: This purchase raised Methanex's stake to 2.46% of Orion's 13F reportable AUM, indicating its growing significance within the investment portfolio.
- Strong Market Performance: Methanex's stock surged 45% over the past year, significantly outperforming the S&P 500's 21% gain, highlighting the company's competitive edge and robust market demand in the chemical sector.
- Solid Financial Health: Methanex reported annual revenue of $3.6 billion in its latest earnings, and despite a decline in net income, the company remains focused on its deleveraging plan, demonstrating resilience in an uncertain economic environment.
- Share Acquisition: Orion Resource Partners acquired 77,291 shares of Methanex in Q4, with an estimated transaction value of $2.88 million, reflecting confidence in Methanex's future growth potential.
- Value Increase: The total position value in Methanex rose by $3.06 million due to both the increase in shares and price movements, indicating a positive market response to the company's performance.
- Financial Results: Methanex reported annual revenue of $3.6 billion, slightly down from the previous year, with net income of $145 million, showcasing significant achievements despite ongoing macroeconomic uncertainties.
- Market Outlook: Benefiting from rising methanol prices and improving supply dynamics, particularly amid U.S.-Iran tensions, Methanex's stock surged approximately 30% this year, highlighting its strong position in the chemical sector.










